Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB4A | P04350 | 3/20 | 0.63 |
| ▸ | TUBB | P07437 | 3/20 | 0.63 |
| ▸ | TUBA3C | P0DPH7 | 3/20 | 0.63 |
| ▸ | TUBA1B | P68363 | 3/20 | 0.63 |
| ▸ | TUBA4A | P68366 | 3/20 | 0.63 |
| ▸ | TUBB4B | P68371 | 3/20 | 0.63 |
| ▸ | TUBB3 | Q13509 | 3/20 | 0.63 |
| ▸ | TUBB2A | Q13885 | 3/20 | 0.63 |
| ▸ | TUBB8 | Q3ZCM7 | 3/20 | 0.63 |
| ▸ | TUBA3E | Q6PEY2 | 3/20 | 0.63 |
| ▸ | TUBA1A | Q71U36 | 3/20 | 0.63 |
| ▸ | TUBA1C | Q9BQE3 | 3/20 | 0.63 |
| ▸ | TUBB6 | Q9BUF5 | 3/20 | 0.63 |
| ▸ | TUBB2B | Q9BVA1 | 3/20 | 0.63 |
| ▸ | TUBB1 | Q9H4B7 | 3/20 | 0.63 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15266000 | 0.92 | ALOX5 (0.64) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL8080318 | 0.89 | TPMT (0.54) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL8930357 | 0.84 | TUBB4A (0.52) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL3326825 | 0.83 | TUBB4A (0.63) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL7041914 | 0.83 | LMNA (0.59) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL29002169 | 0.81 | KMT2A (0.49) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL7194178 | 0.81 | ALOX5 (0.50) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL8072167 | 0.80 | CYP3A4 (0.53) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL27568398 | 0.80 | MEN1 (0.51) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL7225909 | 0.79 | MAPT (0.47) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250162980-A1 | METHODS FOR PREPARING MESCALINE | JOURNEY COLAB CORP. | 2025-05-22 | — | — | US | claimed |
| WO-2023164178-A2 | METHODS FOR PREPARING MESCALINE | JOURNEY COLAB CORP. (US) | 2023-08-31 | — | — | WO | claimed |
| US-6398857-B1 | ACCUSTIC PIEZOELECTRIC; HOT MELT INK JET PRINTING; BENZOIC ACID VEHICLE; ALKYL OR PHENYL CARBOXYLIC ACID VISCOSITY MODIFIER; RETAINS DESIRED HARDNESS | XEROX CORPORATION | 2002-06-04 | — | — | US | claimed |
| JP-2306971-A | — | — | None | — | — | JP | disclosed |
| JP-63234262-A | — | — | None | — | — | JP | disclosed |
| US-20250162980-A1 | METHODS FOR PREPARING MESCALINE | JOURNEY COLAB CORP. | 2025-05-22 | — | — | US | disclosed |
| US-20240392220-A1 | BRANDY REPLICAS | AVA FOOD LABS, INC. | 2024-11-28 | — | — | US | disclosed |
| EP-4408967-A1 | BRANDY REPLICAS | AVA FOOD LABS, INC. (US) | 2024-08-07 | — | — | EP | disclosed |
| US-20240245632-A1 | METHODS OF TREATING SUBSTANCE USE DISORDERS USING MESCALINE | JOURNEY COLAB CORP. | 2024-07-25 | — | — | US | disclosed |
| CN-118339274-A | Brandy replica | 艾娃食品实验室股份有限公司 | 2024-07-12 | — | — | CN | disclosed |
| US-20240130988-A1 | Use of stilbene compounds in the preparation of anti-tumor drugs | GUANGZHOU ANHAO PHARMACEUTICAL TECHNOLOGY CO LTD. (CN) | 2024-04-25 | — | — | US | disclosed |
| WO-2001046199-A1 | METHODS AND COMPOUNDS FOR INHIBITING MRP1 | ELI LILLY AND COMPANY (US) | 2001-06-28 | — | — | WO | disclosed |
| WO-1998031697-A1 | ARYL C-GLYCOSIDE COMPOUNDS AND SULFATED ESTERS THEREOF | SANKYO COMPANY, LIMITED (JP) | 1998-07-23 | — | — | WO | disclosed |
| US-5234944-A | Analgesic for mammals | ROUSSEL UCLAF (FR) | 1993-08-10 | — | — | US | disclosed |
| US-5043347-A | Indanes and analgesic compositions and methods thereof | ROUSSEL UCLAF (FR) | 1991-08-27 | — | — | US | disclosed |
| JP-H02306971-A | PHENETYL ALCOHOL DERIVATIVE AND IMMUNE SUPPRESSING AGENT CONTAINING PHENETYL ALCOHOL DERIVATIVE AS ACTIVE INGREDIENT | TSUMURA & CO | 1990-12-20 | — | — | JP | disclosed |
| JP-S63234262-A | ELECTROPHOTOGRAPHIC SENSITIVE BODY | HITACHI CHEM CO LTD | 1988-09-29 | — | — | JP | disclosed |
| US-4244887-A | Substituted ω-pentanorprostaglandins | PFIZER INC. (US) | 1981-01-13 | — | — | US | disclosed |
| US-4087604-A | Substituted ω-pentanorprostaglandins | PFIZER INC. (US) | 1978-05-02 | — | — | US | disclosed |
| US-4024179-A | Substituted ω-pentanorprostaglandins | PFIZER INC. (US) | 1977-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240130988-A1 | Use of stilbene compounds in the preparation of anti-tumor drugs | CD4, CD81, NFATC1 | TUBB4A 1694/4885TUBB 818/4885TUBA3C 3048/4885 |
| US-20240245632-A1 | METHODS OF TREATING SUBSTANCE USE DISORDERS USING MESCALINE | SLC6A12, SLC6A3, TPMT | TUBB4A 2073/4885TUBB 2493/4885TUBA3C 1721/4885 |
| US-20250162980-A1 | METHODS FOR PREPARING MESCALINE | IL4I1, ME3, LIG3 | TUBB4A 374/4885TUBB 1143/4885TUBA3C 692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.